Vaccine poses low risk for adults with high-risk allergies
Highly allergic adults can safely receive the COVID-19 vaccine from Pfizer/BioNTech, a new study suggests.… Read More
3 years ago
Highly allergic adults can safely receive the COVID-19 vaccine from Pfizer/BioNTech, a new study suggests.… Read More